Status
Study
Lead sponsor
Phase
Enrol
UK sites
Start
Active, closed
AstraZeneca
Phase 3
1,157
Edinburgh, Guildford, London, Manchester, Swansea, Taunton
2021-04-26
Active, closed
Sarepta Therapeutics, Inc.
Observational
205
London, Newcastle upon Tyne
2021-04-22
Recruiting
Day One Biopharmaceuticals, Inc.
Phase 2
141
London, Newcastle upon Tyne
2021-04-22
Recruiting
enGene, Inc.
Phase 1/2
350
London
2021-04-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Torquay, London
2021-04-21
Active, closed
Contura
Observational
201
London, Truro
2021-04-21
Active, closed
Novartis Pharmaceuticals
Phase 2
206
West Midlands, London, Manchester
2021-04-19
Recruiting
ModernaTX, Inc.
Phase 1/2
77
Birmingham, London, Manchester
2021-04-15
Recruiting
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Phase 2
28
London
2021-04-15
Active, closed
Incyte Corporation
Phase 3
654
Birmingham, Bristol, Leicester, London, Manchester, Middlesbrough, Sutton, Wolverhampton
2021-04-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,854
Cambridge, London, Northwood
2021-04-14
Active, closed
Takeda
Phase 3
77
London
2021-04-14
Active, closed
Abiomed Inc.
Not applicable
1,252
London
2021-04-13
Active, closed
Geron Corporation
Phase 3
327
London, Oxford
2021-04-12
Active, closed
Novartis Pharmaceuticals
Phase 3
430
Edinburgh, Cardiff, Boston, Cambridge, Liverpool, London, Oxford
2021-04-09
Active, closed
Gossamer Bio USA, Inc.
Phase 2
74
Cambridge, London
2021-04-05
Recruiting
Merck Sharp & Dohme LLC
Phase 2
490
Bristol, Nottingham, Windsor, London, Oxford, Newmarket, Sutton, Manchester
2021-04-05
Active, closed
ALX Oncology Inc.
Phase 2
189
London, Sutton
2021-04-02
Recruiting
Boston Scientific Corporation
Observational
12,500
London, Manchester
2021-03-31
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 3
57
Headington, Edinburgh, London, Newcastle upon Tyne
2021-03-29
Recruiting
Quell Therapeutics Limited
Observational
10
London
2021-03-24
Recruiting
Bristol-Myers Squibb
Phase 3
153
London, Connor Downs
2021-03-23
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
London, Oxford, Sutton
2021-03-18
Active, closed
Gemma Biotherapeutics
Phase 1/2
26
London
2021-03-17
Active, closed
Hoffmann-La Roche
Phase 1/2
241
London
2021-03-15
Active, closed
Novartis Pharmaceuticals
Phase 2
103
Sheffield, London
2021-03-15
Active, closed
Janssen Research & Development, LLC
Phase 1
140
London, Manchester, Surrey
2021-03-12
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
London, Oxford, Boston, Liverpool, Newcastle upon Tyne
2021-03-11
Active, closed
Loxo Oncology, Inc.
Phase 3
238
Aberdeen, Truro, Plymouth, Cottingham, London, Norwich, Swansea, Edinburgh
2021-03-09
Active, closed
BioNTech SE
Phase 2
327
Bebington, Birmingham, Cardiff, Cottingham, Dorchester, Glasgow, London, Manchester
2021-03-08
Recruiting
Syndax Pharmaceuticals
Phase 2
296
Bristol, Cardiff, Glasgow, London
2021-03-04
Active, closed
LifeSprout, Inc.
Not applicable
118
London
2021-03-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Aberdeen, Bath, Nottingham, Southend, London, Northwood, Taunton, Swansea
2021-02-25
Active, closed
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
Phase 3
455
London, Sutton
2021-02-25
Recruiting
Kartos Therapeutics, Inc.
Phase 1/2
84
Leeds, London, Southampton
2021-02-23
Active, closed
Hoffmann-La Roche
Phase 3
270
Glasgow, Leeds, London, Manchester, Nottingham
2021-02-23
Active, closed
Bioverativ, a Sanofi company
Phase 3
261
London, Birmingham, Hampshire
2021-02-23
Recruiting
Biosense Webster, Inc.
Observational
8,000
Leicester, London
2021-02-22
Active, closed
M.A. Med Alliance S.A.
Not applicable
723
Frimley, Leicester, London, Redhill
2021-02-08
Recruiting
Apellis Pharmaceuticals, Inc.
Phase 2
12
London
2021-02-04
Active, closed
Daiichi Sankyo
Phase 2
277
Birmingham, London, Manchester
2021-02-02
Active, closed
Forma Therapeutics, Inc.
Phase 3
450
Leicester, London, Oxford, Sheffield
2021-01-29
Recruiting
Artios Pharma Ltd
Phase 1/2
542
Glasgow, London, Manchester
2021-01-27
Recruiting
BioInvent International AB
Phase 1/2
250
Birmingham, Leicester, London, Manchester, Southampton
2021-01-25
By invitation
Vertex Pharmaceuticals Incorporated
Phase 3
160
London
2021-01-20
Active, closed
Hoffmann-La Roche
Phase 2
920
Glasgow, London, Manchester
2021-01-18
Recruiting
Pfizer
Phase 3
2,100
Leicester, London
2021-01-15
Active, closed
Pfizer
Phase 3
257
London, Swansea
2021-01-15
Active, closed
Genmab
Phase 3
483
Birmingham, London, Norwich, Nottingham, Plymouth, Southampton, Sutton, Truro
2021-01-13
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
217
London, Sutton
2021-01-11
Active, closed
Galderma R&D
Phase 3
500
Dudley, Glasgow, London, Newcastle upon Tyne
2021-01-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Bristol, Cottingham, Glasgow, London, Sutton, Leicester, Manchester
2021-01-10
Recruiting
Change Accelerator in Respiratory Care
Observational
4,550
London
2021-01-01
Active, closed
Replimune, Inc.
Phase 1
123
Bebington, London, Oxford
2020-12-29
Active, closed
Pfizer
Phase 3
841
Newcastle upon Tyne, Sutton, Birmingham, London, Oxford
2020-12-21
Active, closed
Verastem, Inc.
Phase 2
225
Edinburgh, Glasgow, London, Manchester, Sutton
2020-12-21
Active, closed
Daiichi Sankyo
Phase 3
605
London, Manchester, Middlesbrough
2020-12-21
Active, closed
Novartis Pharmaceuticals
Phase 2
17
London
2020-12-18
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
182
London, Oxford, Belfast, Birmingham, Cambridge, Edinburgh, Leeds, Newcastle upon Tyne
2020-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
370
Southampton, Glasgow, Preston, Leicester, London, Edinburgh, Cardiff, Manchester
2020-12-17
Active, closed
Neurocrine Biosciences
Phase 3
182
Cardiff, London, Manchester, Salford
2020-12-16
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
400
Southampton, Glasgow, Preston, Leicester, London, Edinburgh, Cardiff, Manchester
2020-12-16
Active, closed
Principia Biopharma, a Sanofi Company
Phase 3
232
London, Harrow, Manchester, Norfolk, Southampton
2020-12-14
Active, closed
Novartis Pharmaceuticals
Phase 3
404
Bristol, Hertford, Leicester, London, Salford
2020-12-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
672
Aberdeen, Dundee, Taunton, London, Manchester
2020-12-08
Active, closed
GlaxoSmithKline
Phase 2/3
758
Cardiff, Edinburgh, London, Manchester
2020-12-08
Active, closed
Janssen Research & Development, LLC
Phase 3
97
Edinburgh, Glasgow, Leeds, London
2020-12-04
Active, closed
Amgen
Phase 3
135
Leeds, London, Newcastle, Oxford
2020-12-04
Active, closed
Hoffmann-La Roche
Phase 3
769
London, Newcastle upon Tyne, Plymouth
2020-12-03
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Birmingham, Edinburgh, Kent, Leicester, London, Manchester, Surrey
2020-12-02
Active, closed
Hoffmann-La Roche
Phase 2
303
Harlow, London, Nottingham, Peterborough
2020-11-27
Active, closed
Science Corporation
Not applicable
38
London
2020-11-24
Active, closed
AstraZeneca
Phase 3
957
Cambridge, Dundee, Glasgow, Leicester, London, Manchester, Oxford, Surrey
2020-11-17
Active, closed
UCB Biopharma SRL
Phase 1
19
London, Southampton
2020-11-16
Recruiting
Edwards Lifesciences
Not applicable
900
London
2020-11-12
Active, closed
Prevail Therapeutics
Phase 1/2
35
London
2020-11-09
Active, closed
Pfizer
Phase 3
114
Newcastle upon Tyne, Liverpool, London
2020-11-05
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Glasgow, London
2020-11-03
Recruiting
Ellipses Pharma
Phase 1/2
70
London, Manchester
2020-11-02
Recruiting
PMV Pharmaceuticals, Inc
Phase 1/2
300
London, Newcastle upon Tyne
2020-10-29
Active, closed
Hoffmann-La Roche
Phase 3
985
Glasgow, London, Nottingham, Swansea
2020-10-26
Active, closed
Bayer
Phase 3
402
Reading, Colchester, London, Bebington, Scunthorpe, Glasgow, Cardiff, Llanelli
2020-10-20
Active, closed
Exelixis
Phase 3
575
London, Surrey Quays, Taunton, Blackburn, Northwood, Swansea
2020-10-19
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Edinburgh, London, Sutton
2020-10-13
Active, closed
BioMarin Pharmaceutical
Phase 2
20
London, Sheffield
2020-10-10
Active, closed
Hoffmann-La Roche
Phase 3
992
Brighton, Leicester, London, Maidstone, Peterborough, Plymouth, Sutton, Truro
2020-10-09
Active, closed
Hoffmann-La Roche
Phase 3
210
Leeds, London
2020-10-08
Active, closed
AstraZeneca
Phase 3
370
London, Manchester, Newcastle upon Tyne, Sutton
2020-10-02
Active, closed
Spark Therapeutics, Inc.
Phase 1/2
4
Birmingham, London, Salford
2020-10-01
Active, closed
GlaxoSmithKline
Phase 3
302
London, Plymouth, Southampton, Stoke-on-Trent, Sutton
2020-10-01
Recruiting
Smith & Nephew, Inc.
Observational
400
Manchester, Harpenden, Brighton, Burnley, Grantham, London, Bath, Hertford
2020-10-01
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Edinburgh, London, Manchester, Nottingham, Sutton
2020-09-30
Active, closed
AbbVie
Phase 3
527
Cambridge, Exeter, Edinburgh, London, Southampton, Stevenage, Glasgow, Nottingham
2020-09-30
Active, closed
Hoffmann-La Roche
Phase 3
190
London
2020-09-30
Active, closed
Ipsen
Phase 3
161
Newcastle upon Tyne, Belfast, Camberley, Cambridge, Hull, London, Nottingham, Plymouth
2020-09-24
Active, closed
Pfizer
Phase 2
362
Edinburgh, London, Manchester
2020-09-23
Active, closed
argenx
Phase 2
229
London, Oxford, Sheffield
2020-09-18
Active, closed
Janssen Research & Development, LLC
Phase 2
194
London, Sothampton, Sutton
2020-09-17
Recruiting
Epygenix
Phase 3
150
Cardiff, London, Sheffield
2020-09-15
Active, closed
Merck Sharp & Dohme LLC
Phase 2
154
London, Oxford, Nottingham
2020-09-13